EUVIMEDEUVIMED entdecken
Crossref

RP-HPLC Method Development and Validation for Simultaneous Estimation of Selected Phlebotonic Drug and Its Impurities

Sutar Shubhangi, Jadhav Rutika, Pranjali Pradhane, Anita Bandgar, Prachi Buddhe, Akshay Powar, Samrat Ghatage, Arpita Pawar, Umesh Patil, Sachin S. Mali

International Journal of Drug Delivery Technology · 30.05.2026 · 16 (37s)

DOI: 10.25258/ijddt.16.37s.115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 30.05.2026. Verfasst von Sutar Shubhangi und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This work seeks to develop and validate analytical method by UV and HPLC for the analysis of Diosmin and its two impurities (E & F); looking forward to be this method suitable for a future test analysis. The Zorbax Bonus RP Agilent (250 x 4.6 mm, 5µm) column was utilised with a temperature of 30°C, a volume of 20 µL for injection, a flow rate of 1 mL/min, and a detection wavelength of 348 nm using a PC-enabled (software: Lab solution) and the mobile phase composition of 0.1% perchloric acid: methanol (45%: 55%, v/v). UV-visible double beam spectrophotometer (Make: SHIMADZU, Model: 1900) and pair of matched quartz cells used for UV-visible spectrophotometric analysis. The developed method's linearity, accuracy, precision, LOD, and LOQ were all validated. The method shows linearity in concentration range between (10-60 µg/ml) for Diosmin and 1-6 µg/ml for impurities E and F, respectively, with r² of 0.999 for UV analysis. Method was validated for robustness, linearity, accuracy, precision, LOD, and LOQ for Diosmin and its impurities (Imp E and F). The HPLC method exhibits linearity with r² of 0.999 for Diosmin and its both impurities E and F. The LOD were found to be 0.28, 0.86 and 0.35 µg/mL and LOQ were found to be 1.07, 0.25 and 0.75 µg/mL, respectively. Following ICH Q2 R1 guidelines, the developed UV and RP-HPLC technique was verified and found to be accurate, precise, and economical.

Zitieren

APA

Shubhangi, S., Rutika, J., Pradhane, P., Bandgar, A., Buddhe, P., Powar, A., Ghatage, S., Pawar, A., Patil, U., & Mali, S. S. (2026). RP-HPLC Method Development and Validation for Simultaneous Estimation of Selected Phlebotonic Drug and Its Impurities. International Journal of Drug Delivery Technology, 16(37s). https://doi.org/10.25258/ijddt.16.37s.115

Vancouver

Shubhangi S, Rutika J, Pradhane P, Bandgar A, Buddhe P, Powar A, et al. RP-HPLC Method Development and Validation for Simultaneous Estimation of Selected Phlebotonic Drug and Its Impurities. International Journal of Drug Delivery Technology. 2026;16(37s). doi:10.25258/ijddt.16.37s.115

BibTeX
@article{Shubhangi2026,
  author = {Shubhangi, Sutar and Rutika, Jadhav and Pradhane, Pranjali and Bandgar, Anita and Buddhe, Prachi and Powar, Akshay and Ghatage, Samrat and Pawar, Arpita and Patil, Umesh and Mali, Sachin S.},
  title = {RP-HPLC Method Development and Validation for Simultaneous Estimation of Selected Phlebotonic Drug and Its Impurities},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {37s},
  doi = {10.25258/ijddt.16.37s.115}
}
Kostenlos starten →